These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29685844)

  • 1. CAR T-cells: A John von Neumann legacy?
    Quesnel B
    Curr Res Transl Med; 2018 May; 66(2):35-36. PubMed ID: 29685844
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel targets and technologies for CAR-T cells in multiple myeloma and acute myeloid leukemia.
    Prommersberger S; Jetani H; Danhof S; Monjezi R; Nerreter T; Beckmann J; Einsele H; Hudecek M
    Curr Res Transl Med; 2018 May; 66(2):37-38. PubMed ID: 29655962
    [No Abstract]   [Full Text] [Related]  

  • 3. Celyad's novel CAR T-cell therapy for solid malignancies.
    Lonez C; Hendlisz A; Shaza L; Aftimos P; Vouche M; Donckier V; Machiels JH; Van Den Eynde M; Canon JL; Carrasco J; Odunsi K; Sahebjam S; Rottey S; Braun N; Verma B; Gilham DE; Lehmann FF
    Curr Res Transl Med; 2018 May; 66(2):53-56. PubMed ID: 29625833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beginning the CAR T cell therapy revolution in the US and EU.
    Grupp S
    Curr Res Transl Med; 2018 May; 66(2):62-64. PubMed ID: 29656949
    [No Abstract]   [Full Text] [Related]  

  • 5. CRISPR/Cas9 genome editing: Fueling the revolution in cancer immunotherapy.
    Liu X; Zhao Y
    Curr Res Transl Med; 2018 May; 66(2):39-42. PubMed ID: 29691200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAR-T Cells and Oncolytic Viruses: Joining Forces to Overcome the Solid Tumor Challenge.
    Guedan S; Alemany R
    Front Immunol; 2018; 9():2460. PubMed ID: 30405639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling CAR-T therapy in humanized mice.
    Wu Y; Yu XZ
    EBioMedicine; 2019 Feb; 40():25-26. PubMed ID: 30665855
    [No Abstract]   [Full Text] [Related]  

  • 8. Serving "a la CAR-T": Value-Based Pricing and Gene Therapy.
    Tempero M
    J Natl Compr Canc Netw; 2017 Oct; 15(10):1179. PubMed ID: 28982741
    [No Abstract]   [Full Text] [Related]  

  • 9. Advances in off-the-shelf CAR T-cell therapy.
    Benjamin R
    Clin Adv Hematol Oncol; 2019 Mar; 17(3):155-157. PubMed ID: 30969953
    [No Abstract]   [Full Text] [Related]  

  • 10. Safer CAR T-Cell Therapy.
    Abbasi J
    JAMA; 2019 Jun; 321(22):2155. PubMed ID: 31184718
    [No Abstract]   [Full Text] [Related]  

  • 11. CAR T-cell therapy against B-cell maturation antigen in multiple myeloma.
    Cohen AD
    Clin Adv Hematol Oncol; 2018 Dec; 16(12):804-806. PubMed ID: 30843888
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combining CAR-T cells anti-tumoral activity with exosomes properties: an innovative approach to fight cancer].
    Fusilier Z; Ferran H
    Med Sci (Paris); 2020; 36(6-7):655-658. PubMed ID: 32614317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [NKG2D CAR-T cells as an immunotherapy in hepatocellular carcinoma].
    Roussine Codo G; Khennas S
    Med Sci (Paris); 2020; 36(6-7):662-664. PubMed ID: 32614319
    [No Abstract]   [Full Text] [Related]  

  • 14. Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases.
    Magee MS; Abraham TS; Baybutt TR; Flickinger JC; Ridge NA; Marszalowicz GP; Prajapati P; Hersperger AR; Waldman SA; Snook AE
    Cancer Immunol Res; 2018 May; 6(5):509-516. PubMed ID: 29615399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical units to set up chimeric antigen receptor T-cell therapy (CAR T-cells): Based on the recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
    Yakoub-Agha I
    Curr Res Transl Med; 2018 May; 66(2):57-58. PubMed ID: 29685843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric antigen-receptor T-cell therapy for hematological malignancies and solid tumors: Clinical data to date, current limitations and perspectives.
    Gauthier J; Yakoub-Agha I
    Curr Res Transl Med; 2017 Sep; 65(3):93-102. PubMed ID: 28988742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors.
    Zhang E; Gu J; Xu H
    Mol Cancer; 2018 Jan; 17(1):7. PubMed ID: 29329591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid based low viscosity hydrogel as a novel carrier for Convection Enhanced Delivery of CAR T cells.
    Atik AF; Suryadevara CM; Schweller RM; West JL; Healy P; Herndon Ii JE; Congdon KL; Sanchez-Perez L; McLendon RE; Archer GE; Fecci P; Sampson JH
    J Clin Neurosci; 2018 Oct; 56():163-168. PubMed ID: 30041899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CAR T-cells for relapsed B-cell ALL in adults.
    Gilbert JA
    Lancet Oncol; 2018 Mar; 19(3):e143. PubMed ID: 29429915
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic engineering of T cells with chimeric antigen receptors for hematological malignancy immunotherapy.
    Ti D; Niu Y; Wu Z; Fu X; Han W
    Sci China Life Sci; 2018 Nov; 61(11):1320-1332. PubMed ID: 30414005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.